Why hasn’t evolution dealt with the inefficiency of

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone wowhappens28 #20294
245
Why hasn’t evolution dealt with the inefficiency of ageing?
Jordan Pennells < >

a PhD student in bioengineering at the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland in Brisbane. He is researching sustainable plant-based nanomaterials.

Life pits the order and intricacy of biology against the ceaseless chaos of physics. The second law of thermodynamics, or the thermodynamic arrow of time, states that any natural system will always tend towards increasing disorder. Biological ageing is no different, making death inevitable. However, one of the least-addressed questions of ageing is the apparent paradox between the optimising drive of evolution, and the inevitable deterioration of the body. Considering the 3.5 billion years in which we have evolved from single-cell organisms, why hasn’t life countered the inefficiency of ageing? Or more accurately, how has ageing persisted within the Darwinian framework of evolution?

For evolution to occur, there must first be genetic variation, a difference between individuals within a population for a measurable characteristic (phenotype) arising from genetic and environmental factors; inheritance of these genetic factors from parents to their offspring; and differential reproductive success, such that certain genetic factors manifest themselves in an individual’s capability to survive and reproduce (ie, fitness).

Consider ageing in this evolutionary framework. There is an obvious variation in lifespan across different individuals throughout the world, impacted by genetic factors, but also influenced strongly by external factors such as the country’s gross domestic product.

Lifespan is also an inherited trait, with approximately 23 to 26 per cent of the variation in lifespan between individuals caused by genetic factors, otherwise known as heritability. Moreover, it makes sense that an increased lifespan, or improved health over your life leading to an increased lifespan, would render you more attractive to the other sex, and increase your likelihood of reproductive success. So if these three evolutionary criteria have been met for the trait of longevity, why don’t we live for an unheralded number of years?

In 1952, the British biologist Peter Medawar formalised the first evolutionary theory of ageing, terming it the mutation-accumulation model. This theory relies upon the fact that mutations acquired by an individual can be early acting or late-onset. Early acting mutations manifest themselves during the period where individuals are reproductively active, so that whatever effect the mutation has will be acted upon by natural selection. However, natural selection is ‘blind’ to late-onset mutations. Mutations that reveal themselves later in life cannot be retroactively selected against, if reproduction has already occurred, and passed on to the next generation. Therefore, the force of selection diminishes with age and reproductive decline. This phenomenon is known as the selection shadow.

The selection shadow is the diminished force of selection with age and reproductive decline. Source: Fabian and Flatt, 2011

1_2.jpg

This theory contributes to why it is so difficult to breed animals in captivity till ages later than they’d naturally experience in the wild. When their environment changes and survival risks are lifted, such as in captivity, animals can live to an age where accumulated late-onset mutations can manifest themselves. This effect is exaggerated by mutation concentration due to inbreeding in these small populations. Conservationists have great difficulty dealing with the elevated level of these age-related diseases, which are not seen at such rates in the wild. A similar phenomenon has been observed with the rise of neurodegenerative diseases in human populations, co-occurring with our drastic increase in lifespan over the past century.

The mutation-accumulation model was refined in 1957 by the American evolutionary biologist George C Williams, when he elaborated further on the relationship between early acting and late-onset mutations. A mutation can have multiple effects that present themselves differently in different tissue types, or different stages of life, a genetic phenomenon known as pleiotropy. When the mutation has opposing effects on fitness at different life stages, for example during early and late life, it is known as antagonistic pleiotropy. Williams postulated that if a mutation has a beneficial effect on survival and reproduction in early life, but a negative ageing-related impact in later life, selection will act upon the early benefit and enrich this mutation in the population. This antagonistic-pleiotropy model presents ageing as a maladaptive byproduct of selection for survival and reproduction during youth.

So it was established that some early life traits that improved survival and reproduction had an evolutionary trade-off against age-related disorders. However, in 1977 the English biologist Thomas Kirkwood advanced this concept with the disposable soma model, which proposes an evolutionary trade-off between survival and reproduction themselves. Kirkwood argued that, in an environment with limited resources, each individual must budget resources toward either survival or reproduction. Think about it like your choice when buying a new car. You might purchase a flashy new sports car that goes from 0-100km/h in 2.7 seconds, enjoy the thrill, and maybe catch the eye of some prospective partners in the process. But this car is pricey, and the car’s acceleration and speed might not be safe.

The same concept of reproductive costs and risks is observed throughout nature. These are the factors that species must weigh up and contend with in their endeavour to find a suitable mate:

Search costs: finding a mate out in the reproductive wilderness can cost time and money – or, in nature, it will cost metabolic energy and the risk of predation;
Carrying/rearing costs: gestation and rearing of offspring is energetically costly, as well as increasing the parent’s vulnerability to predation;
Disease risks: interaction with a mate can lead to contact-driven diseases;
Mating risks: female humans are at more risk of domestic violence than human males, but the roles can be reversed in nature, with the female of certain species consuming the unsuspecting male post-copulation (eg, the female praying mantis cannibalises her partner after mating).

While reproduction can be costly, if you are successful, the end justifies the means. But when it comes to which of these strategies individuals employ, the environment can be of great significance. In one experiment from 2004, male field crickets were reared in captivity and fed low to high levels of protein as part of their diet. To attract potential partners, male crickets rub their hind legs against their abdomen to produce the call that we hear in the evening. This is not only metabolically costly, but alerts their presence to predators. Males that were fed an energy-rich, high-protein diet allocated these resources towards night-calling at the detriment of cellular maintenance. This led to reduced longevity, even in the absence of predators.

Ultimately, reproduction is the focal point by which evolution acts. Human evolution permits late-onset effects on health that arise after this reproduction window, especially if it benefits individuals in their early life exploits. In the context of environmental constraints, the individual must effectively allocate resources, creating trade-offs between reproduction, safety and long-term health. In the drive towards the cure for ageing, evolutionary medicine has the potential to further our understanding of why human diseases arise, and elucidate the unanticipated costs of subverting this intrinsic biological process.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 69

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 80

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 18

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 118

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading

Top 5 Most Recently Viewed Articles

Rockpool Acquisitions Faces Trading Suspension from FCA

Updated Category News Views 230

Trading Suspension of Rockpool Acquisitions Plc Shares LONDON - Recently, the Financial Conduct Authority (FCA) announced an immediate suspension of Rockpool Acquisitions Plc's ordinary shares from the Official List. The suspension was requested by the company itself and serves to protect the interests of investors and maintain market integrity. Details of the Suspension...

Continue Reading
Discover the Growth of Linde Stock Over the Past Decade

Updated Category News Views 262

Linde Stock Performance: A Decade in Review Linde (NASDAQ: LIN) has exhibited exceptional performance in the stock market over the past ten years, showcasing an impressive annualized return of 13.72%. This growth has outpaced the overall market by 2.12%, demonstrating the strength of Linde's business strategies and market presence. Investment Growth Over Ten Years If an...

Continue Reading
Exploring Saudi Arabia's Economic Growth Trends in Q3

Updated Category News Views 377

Saudi Arabia's Economic Overview in Q3 In a remarkable turn of events, Saudi Arabia's economy has reported a year-over-year growth of 2.8% for the third quarter. This growth, as unveiled by preliminary government statistics, has been largely fueled by robust performance in non-oil sectors, indicating a diversification effort from the nation. This positive trend is a...

Continue Reading
ANTHBOT's Quiet Drive Mirrors Athlete's Steadfastness

Updated Category News Views 4

Unveiling Consistent Performance Just like a goalkeeper defends the goal, ANTHBOT defends your lawn—silently and consistently. Partnering up with German goalkeeper Marc ter Stegen in their latest campaign, ANTHBOT is airing a TV blitz across ARD, ZDF, and digital platforms. This ain't just some ad blitz; it's a thoughtful nudge toward understanding how regular, quiet,...

Continue Reading
WisdomTree Earns 2024 Best Places to Work Honors Again

Updated Category News Views 162

WisdomTree Achieves Recognition in Employee Satisfaction WisdomTree, Inc. (NYSE: WT), known for its pioneering approach in the finance sector, has been celebrating another significant achievement. Recognized as a 2024 Best Places to Work in Money Management, this marks the fifth consecutive year the company has attained this honor. The accolades stem from a robust survey...

Continue Reading